Lisa Anson

Lisa Anson serves as Chief Executive Officer at Redx Pharma. Redx Pharma operates in the pharmaceuticals sector with approximately 79.0 employees. The company is headquartered in Stockport, England. Redx Pharma generates annual revenue of 13529000.0.

Industry & Role Insights

• • MessageCEO tracks 1,288 executives in the pharmaceuticals sector.
• • 10,137 executive contacts are available in England.
• • Our database includes 201,469 c suite-level executives.

Outlook DigitalOcean Hotjar Nginx Google Font API Google Tag Manager WordPress.org Google Analytics Gravity Forms Vimeo Mobile Friendly

oncology fibrosis pharmaceuticals drug discovery & development biotech pharmaceutical manufacturing biotechnology drug discovery clinical development fibrotic diseases cancer therapies rock inhibitors zelasudil rxc008 gi-targeted pan-rock fibrostenotic crohns disease preclinical models translational science drug candidates clinical trials cancer-associated fibrosis preclinical data phase 1 study phase 2 data surgical treatment anti-fibrotic therapies inflammatory bowel disease foxfire trials biologics small molecule therapies underlying mechanisms therapeutic efficacy medicinal chemistry mechanism of action pharmacokinetics safety profiles cyp450 interactions therapeutic targets clinical endpoints secondary complications disease progression patient populations longitudinal studies cancer biology immune-mediated lung disease collaborative research key opinion leaders expert advisors biomarkers proof of concept enrollment criteria investigator-initiated studies future directions patient derived xenografts clinical-stage targeted therapies small molecules cancer treatment idiopathic pulmonary fibrosis rock2 inhibitor innovative medicines healthcare professionals patient outcomes unmet medical needs collaborations partnerships gastrointestinal diseases crohn's disease wnt-ligand dependent tumors strategic deals first-in-class best-in-class drug development healthcare innovation market engagement investor relations precision medicine therapeutic areas customer service patient-centric research & development competitive landscape emerging biotechs pharmaceutical industry hospital & health care medical health care health wellness & fitness

YM

Yathendra Madineni Chief Executive Officer at 4C Pharma Solutions

RB

Ronan Brown Chief Operating Officer at 4G Clinical

HK

Hitoshi Kamiya Chief Executive Officer at A2 Healthcare Corporation

LJ

Lars Jensen CEO at A-apoteket

TL

Tien Lee CEO at Aardvark Therapeutics, Inc.

Outreach Guidance — pharmaceuticals Sector

Executives like Lisa Anson in the pharmaceuticals sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Redx Pharma.

How do I reach Lisa Anson directly?

Lisa Anson's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Executive Officer at Redx Pharma. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Lisa Anson work for?

Lisa Anson is Chief Executive Officer at Redx Pharma, a company in the pharmaceuticals sector with 79.0 employees. The company is based in Stockport, England.

Can I pitch or sell to Lisa Anson?

As Chief Executive Officer at Redx Pharma, Lisa Anson is a key decision-maker in the pharmaceuticals sector. MessageCEO Pro gives you verified email to reach Lisa Anson directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Lisa Anson in?

Lisa Anson works in the pharmaceuticals industry as Chief Executive Officer at Redx Pharma. MessageCEO provides verified contact information for executives across all major industries.

Is Lisa Anson's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Lisa Anson's profile is kept up-to-date with the latest available information.

Last updated: May 12, 2026